p16INK4/p15INK4B gene inactivation is a frequent event in malignant T-cell lines

European Journal of Haematology

Volumn 56, Issue 5, 1996, Pages 313-318

  Brandter, Laura Borgonovo ^a   Heyman, Mats ^a   Rasool, Omid ^a   Liu, Yie ^a   Grander, Dan ^a   Einhorn, Stefan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

p16INK4 p15INK4B; T cell lines; Tumor suppressor genes

Indexed keywords

CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PRIMER DNA; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CHROMOSOME 9; CHROMOSOME MAP; DNA PROBE; EXON; GENE DELETION; GENE EXPRESSION; GENETICS; HOMOZYGOTE; HUMAN; INTRON; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE; CONTROLLED STUDY; GENE CONTROL; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

BASE SEQUENCE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; DNA PROBES; EXONS; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HOMOZYGOTE; HUMANS; INTRONS; LEUKEMIA, T-CELL; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE DELETION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030140216     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb00721.x     Document Type: Article

References (35)

1. KORSMEYER S. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immun 1992: 10: 785-807.
2. JONVEAUX P, BERGER R. Infrequent mutation in the p53 gene in primary human T-cell acute lymphoblastic leukemia. Leukemia 1991: 5: 839-840.
3. WADA M, BARTRAM C, NAKAMURA H, et al. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood 1993: 82: 3163-3169.
4. CHEN Y-C, CHEN P-J, YEH S-H, et al. Deletion of human retinoblastoma gene in primary leukemias. Blood 1990: 10: 2060-2064.
5. PHILLIPS R, GILL R, ZACKSENHAUS E, et al. Why don't germline mutations in RB1 predispose to leukemia? Curr Top Microbiol Immun 1992: 182: 485-491.
6. KOWALCZYK J, SANDBERG A. A possible subgroup of ALL with 9p-Cancer Genet Cytogenet 1983: 9: 383-385.
7. CHILCOTE R, BROWN W, ROWLEY J. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. New Engl J Med 1985: 313: 286-291.
8. Pollak C, Hagemeijer A. Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. Leukemia 1987: 1: 541-548.
9. DIAZ M, ZIEMIN S, LEBEAU M, et al. Homozygous deletion of the α- and β1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA 1988: 85: 5259-5263.
10. DIAZ M, RUBIN C, HARDEN A, et al. Deletions of interferon genes in acute lymphoblastic leukemia. New Engl J Med 1990: 322: 77-82.
11. EINHORN S, GRANDER D, BJÖRK O, et al. Deletion of α-, - β and ω-IFN genes in malignant cells from children with acute lymphocytic leukemia. Cancer Res 1990: 50: 7781-7785.
12. FOUNTAIN J, KAAAYIORGOU M, TARUSCIO D, et al. Genetic and physical map of the interferon region on chromosome 9p. Genomics 1992: 14: 105-112.
13. OLOPADE O, BOHLANDER S, POMYKALA H, et al. Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics 1992: 14: 437-443.
14. SERRANO M, HANNON G, BEACH D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993: 366: 704-707.
15. KAMB A, GRUIS N, WEAVER-FELDHAUS J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994: 263: 436-440.
16. NOBORI T, MIURA K, Wu D, et al. Deletions of the cyclin dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994: 368: 753-756.
17. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994: 371: 257-261.
18. ink4 gene inactivation in acute lymphocytic leukemia. Blood 1995: 85: 3431-3436.
19. OGAWA S, HIRANO N, SATO N, et al. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 1994: 84: 2431-2435.
20. QUESNEL B, PREUDHOMME C, PHILIPPE N, et al. P16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 1995: 85: 657-663.
21. INK4B) display frequent homozygous deletions in primary cell from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood 1994: 84: 4038-4044.
22. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995: 85: 2321-2330.
23. HEYMAN M, GRANDER D, BRONDUM-NIELSEN K, et al. Interferon system defects in malignant T-cells. Leukemia 1994: 8: 425-434.
24. FRIEND S, BERNARDS R, ROGEL S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986: 323: 643-646.
25. TSUJIMOTO Y, BASHIR M, GIVOL I, et al. DNA rearrangements in human follicular lymphoma can involve the 5′ or 3′ region of the bcl-2 gene. Proc Natl Acad Sci USA 1987: 84: 1329-1331.
26. HEYMAN M, GRANDER D, BRONDUM-NIELSEN K, et al. Deletions of the short arm of chromosome 9, including the interferon-α/β genes, in acute lymphocytic leukemia. Studies on loss of heterozygosity, parental origin of deleted genes and prognosis. Intern J Cancer 1993: 54: 748-753.
27. HIRAMA T, KOEFFLER H. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995: 86: 841-854.
28. KAMB A. Cell-cycle regulators and cancer. Trends Genet 1995: 11: 136-140.
29. INK4 in human cancer. Proc Natl Acad Sci, USA 1994: 91: 11045-11049.
30. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 1994: 9: 3375-3378.
31. LIU Y, SZEKELY L, GRANDER D, et al. Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of a adjacent locus. Proc Natl Acad Sci, USA 1993: 90: 8697-8701.
32. CAIRNS P, MAO L, MERLO A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994: 265: 415-416.
33. SPRUCK III C, GONZALES-ZULUETA M, SHIBATA A, et al. p16 gene in cultured tumours. Nature 1994: 370: 183-184.
34. YEAGER T, STADLER W, BELAIR C, et al. Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res 1995: 55: 493-497.
35. ZHANG S-Y, KLEIN-SZANTO A, SAUTER E, et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 1994: 54: 5050-5053.